Related references
Note: Only part of the references are listed.Polymer Encapsulated Liposomes for Oral Co-Delivery of Curcumin and Hydroxytyrosol
Vincenzo De Leo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
A step to shell biorefinery-Extraction of astaxanthin-rich oil, protein, chitin, and chitosan from shrimp processing waste
P. A. Aneesh et al.
BIOMASS CONVERSION AND BIOREFINERY (2023)
A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics
Richard N. L. Lamptey et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Thermosensitive in situ hydrogels of rivastigmine-loaded lipid-based nanosystems for nose-to-brain delivery: characterisation, biocompatibility, and drug deposition studies
S. Cunha et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)
Vitamin E prevents lipid peroxidation and iron accumulation in PLA2G6-Associated Neurodegeneration
Irene Villalon-Garcia et al.
NEUROBIOLOGY OF DISEASE (2022)
Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood- brain barrier (BBB) to manage neurological disorders
A. C. Correia et al.
ADVANCED DRUG DELIVERY REVIEWS (2022)
Fiscalin Derivatives as Potential Neuroprotective Agents
Sandra Barreiro et al.
PHARMACEUTICS (2022)
In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN)
Claudia Pina Costa et al.
PHARMACEUTICALS (2021)
Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders
Mariano Catanesi et al.
MARINE DRUGS (2021)
Haematococcus pluvialis as a Potential Source of Astaxanthin with Diverse Applications in Industrial Sectors: Current Research and Future Directions
Siti Nur Hazwani Oslan et al.
MOLECULES (2021)
Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer's Disease: Formulation Development and Optimization
Debora Santonocito et al.
NANOMATERIALS (2021)
Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies
Claudia Pina Costa et al.
ACTA PHARMACEUTICA SINICA B (2021)
Lipid Nanoparticles Containing Mixtures of Antioxidants to Improve Skin Care and Cancer Prevention
Catarina Goncalves et al.
PHARMACEUTICS (2021)
Anti-Alzheimer's Molecules Derived from Marine Life: Understanding Molecular Mechanisms and Therapeutic Potential
Md. Tanvir Kabir et al.
MARINE DRUGS (2021)
Characterization of Astaxanthin Nanoemulsions Produced by Intense Fluid Shear through a Self-Throttling Nanometer Range Annular Orifice Valve-Based High-Pressure Homogenizer
Gary B. Smejkal et al.
MOLECULES (2021)
Improving Drug Delivery for Alzheimer's Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels
Sara Cunha et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)
Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: Toxicological effect of surface charge on human neuronal cells
C. P. Costa et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Marine Bacteria versus Microalgae: Who Is the Best for Biotechnological Production of Bioactive Compounds with Antioxidant Properties and Other Biological Applications?
Masoud Hamidi et al.
MARINE DRUGS (2020)
Bioactives from Agri-Food Wastes: Present Insights and Future Challenges
Sana Ben-Othman et al.
MOLECULES (2020)
Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters
Sara Cunha et al.
PHARMACEUTICS (2020)
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Gill Livingston et al.
LANCET (2020)
Oxidative Stress and Marine Carotenoids: Application by Using Nanoformulations
Yasin Genc et al.
MARINE DRUGS (2020)
Pessaries containing nanostructured lipid carriers (NLC) for prolonged vaginal delivery of progesterone
A. Correia et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer's disease using Box-Behnken design
Gifty M. Jojo et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2019)
Enzyme-assisted extraction of astaxanthin from Haematococcus pluvialis and its stability and antioxidant activity
Xiaoyan Zhao et al.
FOOD SCIENCE AND BIOTECHNOLOGY (2019)
Carvacrol and astaxanthin co-entrapment in beeswax solid lipid nanoparticles as an efficient nano-system with dual antioxidant and anti-biofilm activities
Mohammad Shakeri et al.
LWT-FOOD SCIENCE AND TECHNOLOGY (2019)
The Neuroprotective Effects of Astaxanthin: Therapeutic Targets and Clinical Perspective
Sajad Fakhri et al.
MOLECULES (2019)
Astaxanthin: A Potential Mitochondrial-Targeted Antioxidant Treatment in Diseases and with Aging
Monika Sztretye et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Insights into the Discovery of Novel Neuroprotective Agents: A Comparative Study between Sulfanylcinnamic Acid Derivatives and Related Phenolic Analogues
Daniel Chavarria et al.
MOLECULES (2019)
Waste-to-wealth: biowaste valorization into valuable bio(nano)materials
Chunping Xu et al.
CHEMICAL SOCIETY REVIEWS (2019)
Development of a PEGylated-Based Platform for Efficient Delivery of Dietary Antioxidants Across the Blood - Brain Barrier
Carlos Fernandes et al.
BIOCONJUGATE CHEMISTRY (2018)
Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review
A. Garces et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
On the Neuroprotective Role of Astaxanthin: New Perspectives?
Christian Galasso et al.
MARINE DRUGS (2018)
Inhibitory Effect of Astaxanthin on Oxidative Stress-Induced Mitochondrial Dysfunction-A Mini-Review
Suhn Hyung Kim et al.
NUTRIENTS (2018)
Astaxanthin-Loaded Nanostructured Lipid Carriers for Preservation of Antioxidant Activity
Violeta Rodriguez-Ruiz et al.
MOLECULES (2018)
Chemical stability of astaxanthin integrated into a food matrix: Effects of food processing and methods for preservation
Alejandra Anahi Martinez-Delgado et al.
FOOD CHEMISTRY (2017)
Characterization and biocompatibility evaluation of cutaneous formulations containing lipid nanoparticles
F. Eiras et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
New neurons in adult brain: distribution, molecular mechanisms and therapies
Annachiara Pino et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Preparation and stability of astaxanthin solid lipid nanoparticles based on stearic acid
Miaomiao Li et al.
EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY (2016)
Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products
Michele Pozzoli et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs
Vanessa S. S. Goncalves et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Protection against MPP+-induced neurotoxicity in SH-SY5Y cells by tormentic acid via the activation of PI3-K/Akt/GSK3β pathway
Qing Zhao et al.
NEUROCHEMISTRY INTERNATIONAL (2016)
Nose to brain delivery of astaxanthin-loaded solid lipid nanoparticles: fabrication, radio labeling, optimization and biological studies
Prakash Chandra Bhatt et al.
RSC ADVANCES (2016)
Astaxanthin from Haematococcus pluvialis Prevents Oxidative Stress on Human Endothelial Cells without Toxicity
Philippe Regnier et al.
MARINE DRUGS (2015)
The Characterization of the Human Nasal Epithelial Cell Line RPMI 2650 Under Different Culture Conditions and Their Optimization for an Appropriate in vitro Nasal Model
Mateja Erdani Kreft et al.
PHARMACEUTICAL RESEARCH (2015)
The mixture of ecstasy and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations
Daniel Jose Barbosa et al.
ARCHIVES OF TOXICOLOGY (2014)
Colchicine effect on P-glycoprotein expression and activity: In silico and in vitro studies
Renata Silva et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2014)
EDTA and α-tocopherol improve the chemical stability of astaxanthin loaded into nanostructured lipid carriers
Fardin Tamjidi et al.
EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY (2014)
Design and characterization of astaxanthin-loaded nanostructured lipid carriers
Fardin Tamjidi et al.
INNOVATIVE FOOD SCIENCE & EMERGING TECHNOLOGIES (2014)
Pinocembrin Protects SH-SY5Y Cells Against MPP+-Induced Neurotoxicity Through the Mitochondrial Apoptotic Pathway
Yumin Wang et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2014)
Neuroprotective effects of metabotropic glutamate receptor group II and III activators against MPP(+)-induced cell death in human neuroblastoma SH-SY5Y cells: The impact of cell differentiation state
D. Jantas et al.
NEUROPHARMACOLOGY (2014)
Network hubs in the human brain
Martijn P. van den Heuvel et al.
TRENDS IN COGNITIVE SCIENCES (2013)
Risperidone Release from Solid Lipid Nanoparticles (SLN): Validated HPLC Method and Modelling Kinetic Profile
A. C. Silva et al.
CURRENT PHARMACEUTICAL ANALYSIS (2012)
Bioactive Peptides and Depsipeptides with Anticancer Potential: Sources from Marine Animals
Guadalupe-Miroslava Suarez-Jimenez et al.
MARINE DRUGS (2012)
Bioactive peptides from marine processing waste and shellfish: A review
Padraigin A. Harnedy et al.
JOURNAL OF FUNCTIONAL FOODS (2012)
Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery
Surajit Das et al.
AAPS PHARMSCITECH (2011)
Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): High pressure homogenization versus ultrasound
A. C. Silva et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2011)
Astaxanthin protects against MPTP/MPP plus -induced mitochondrial dysfunction and ROS production in vivo and in vitro
Dae-Hee Lee et al.
FOOD AND CHEMICAL TOXICOLOGY (2011)
Ternary Complexes of Iron, Amyloid-β, and Nitrilotriacetic Acid: Binding Affinities, Redox Properties, and Relevance to Iron-Induced Oxidative Stress in Alzheimer's Disease
Dianlu Jiang et al.
BIOCHEMISTRY (2009)
Astaxanthin inhibits reactive oxygen species-mediated cellular toxicity in dopaminergic SH-SY5Y cells via mitochondria-targeted protective mechanism
Xuebo Liu et al.
BRAIN RESEARCH (2009)
Trends in the Molecular Pathogenesis and Clinical Therapeutics of Common Neurodegenerative Disorders
Yahya E. Choonara et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2009)
Production and characterization of Hesperetin nanosuspensions for dermal delivery
Prabhat R. Mishra et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells
Francisco Molina-Holgado et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Neutral red uptake assay for the estimation of cell viability/cytotoxicity
Guillermo Repetto et al.
NATURE PROTOCOLS (2008)
SAG protects human neuroblastoma SH-SY5Y cells against 1-methyl-4-phenylpyridinium ion (MPP+)-induced cytotoxicity via the downregulation of ROS generation and JNK signaling
Sun-Yee Kim et al.
NEUROSCIENCE LETTERS (2007)
Oxidants, antioxidants and the ischemic brain
DS Warner et al.
JOURNAL OF EXPERIMENTAL BIOLOGY (2004)
Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists
SP Presgraves et al.
NEUROTOXICITY RESEARCH (2004)
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations
RH Müller et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Solid lipid nanoparticles -: Production, characterization and applications
W Mehnert et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Share Paper
